InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-38.1%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Herskowitz Neil, Director. Officer active across 4 companies, notably Avenue Therapeutics, INC.. Cumulatively, 21 reports have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €17k. Activity tracked since 6 May 2021. The latest transaction was disclosed on 28 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations21 total
10,000 sharesCommon Stock, $0.0001 par valueSEC:0001104659-26-078282:0
12,195 shares0COMMON STOCKSEC:0001104659-25-054688:0
17,638 shares0COMMON STOCKSEC:0001104659-24-129522:0
23 shares@ US$2.000.3% of flowCOMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-125093:0
9,728 shares0Common Stock, $0.0001 par valueSEC:0001104659-24-078972:0
32,051 shares0COMMON STOCKSEC:0001104659-24-062663:0
27,472 shares0Common Stock, par value $0.0001 per shareSEC:0001104659-23-083836:0
7,246 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-079111:0
17,483 shares0COMMON STOCKSEC:0001104659-23-071758:0
71,664 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-040929:0
14,245 shares0Common Stock, par value $0.0001 per shareSEC:0001104659-22-082288:0
47,619 shares0COMMON STOCKSEC:0001104659-22-074467:0
30,000 shares0COMMON STOCKSEC:0001104659-22-042276:0
49,020 shares0Common StockSEC:0001104659-21-152198:0
49,020 shares0Common StockSEC:0001104659-21-152198
13,774 shares0COMMON STOCKSEC:0001104659-21-090240:0
13,774 shares0COMMON STOCKSEC:0001104659-21-090240
16,502 shares0COMMON STOCKSEC:0001104659-21-080361
16,502 shares0COMMON STOCKSEC:0001104659-21-080361:0
2,500 shares@ US$3.9950.0% of flowCommon StockSEC:0001104659-21-062774
Ideal exit: 31 Jan 2022 (T+270)
2,500 shares@ US$3.990.38% mcap50.0% of flowCommon StockSEC:0001104659-21-062774:0
Ideal exit: 31 Jan 2022 (T+270)
21 of 21 declarations
About Herskowitz Neil
Neil Herskowitz is a Board Member at Avenue Therapeutics, Inc., Checkpoint Therapeutics, Inc., and Mustang Bio, Inc. As a board member, he contributes to the governance and strategic direction of these companies. Neil brings his expertise to help guide strategic decisions and ensure compliance with regulations.
